Drug Trial Radar · NCT05227937
Single Dose Amikacin for Uncomplicated Cystitis in the ED: A Feasibility Study
Last checked: Nov 20, 2026Latest source record: Sep 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
75
Planned (sponsor's estimate)
Start
Sep 21, 2022
Primary completion
May 31, 2026
Study completion Dec 31, 2026
Sponsor
- Lead sponsor
- Antonios LikourezosAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Feb 8, 2022
Design
- Study type
- Observational
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 14 years, up to 110 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine if a single dose of amikacin (a type of antibiotic) can be used to effectively treat emergency department patients with uncomplicated cystitis (inflammation of the bladder). Participating in this study will allow the patient to treat their urinary tract infection (UTI) with a single intramuscular (IM (into the arm)) or intravenous (IV (into the vein)) shot of amikacin, rather than having to go to the pharmacy to pick up a prescription for antibiotics, and then take antibiotics for 3-7 days. A single dose of amikacin has been demonstrated to be safe, effective and well tolerated in other studies, but some patients may decline to participate because they do not wish to have an IV or IM shot, or because they don't want to speak on the phone with a research assistant three times over the next 30 days.
Conditions
- Urinary Tract Infections
Interventions
AmikacinDrug
patient will be treated with amikacin 15 mg/kg IV or IM, based on actual body weight; for patients \>120% of IBW, we will use AdjBW (IBW + 0.4(ABW-IBW)) rounded to nearest 50 mg. Patients who already have an IV will receive the medication IV, otherwise the dose will be given IM.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Resolution of Urinary Tract Infection SymptomsTime frame: 3 days (72 hours)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Maimonides Medical Center
Brooklyn, New York · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.